CanapaR

RAMM Pharma, a cannabis-based pharmaceutical company with products in several Latin American countries, has bought a 49% stake in the Sicilian CBD processing company Canapar. Based in Toronto, RAMM purchased the shares from the cannabis venture-capital firm Canopy Rivers. Under the agreement, RAMM paid $7 million cash to Canopy Rivers to buy a little more